I know…I’ve been MIA for a bit, but only because I’ve been neck-deep in great research about nutritional strategies for fighting autoimmunity and “inflammaging”. I’ll be presenting the latest findings at the 2017 LDN Autoimmune Conference in September. You can attend online or in person, and the details are here: https://ldnresearchtrust.org/
There are loads of exciting new findings about fighting inflammation and autoimmunity with diet. Patients are more empowered than ever, thanks to new knowledge about “leaky gut” (excessive intestinal permeability) and the role of microbes that live in and on us. Those are huge topics, so I’ll tackle those in future posts, but if you or someone you love has an autoimmune condition, chronic pain, or cancer, you may want to check out the LDN conference.
So what is LDN? It’s low-dose naltrexone, a tiny dose of an old, generic drug once used for treating alcoholism, but coincidentally effective at helping some people with pain, autoimmune conditions, cancer, and more. It appears to work by briefly blocking the brain’s opioid receptors, making the brain upregulate production of and sensitivity to natural endorphins. This translates into less pain, less inflammation and modulation (but not suppression) of the immune system. I learned about it from a top expert, Dr. Pradeep Chopra, a Harvard-trained pain specialist who now teaches at Brown Medical School. It is somewhat controversial because it lacks extensive research for these new applications, but many patients and doctors report that is extremely safe and effective for many otherwise hopeless conditions. Because it is so cheap and generic, drug companies lack a profit-motive for funding clinical trials. If you are interested in learning more, the LDN Research Trust, a grassroots non-profit, is a good starting point: https://ldnresearchtrust.org/